You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Efficient Materials for Optical Cryocoolers

    SBC: ThermoDynamic Films LLC            Topic: CBD171001

    This Phase-II SBIR proposal directly addresses the need to improve the size, weight and power, SWaP, of optical cryocoolers. In particular, the proposers will work toward increasing the efficiency of optical cryocoolers by incorporating cooling materials that require less input laser power to achieve a given heat lift. The new cooling materials will be high-purity crystals doped with active rare-e ...

    SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
  2. A Next Generation, High-Precision, Field Drug Detection System

    SBC: SensoDX II, LLC            Topic: A16AT008

    The synthetic opioids fentanyl and carfentanil pose an imminent national security threat, given the ease with which they can be obtained, their low lethal doses, and their potential for weaponized use. The purpose of this agreement is to adapt SensoDx’s high-performance miniaturized diagnostics platform based on a programmable bio-nano-chip, with embedded artificial intelligence, to enable U.S. ...

    SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
  3. Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment

    SBC: ZYMERON CORPORATION            Topic: CBD181004

    Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  4. Dermal Medical Countermeasures for Chemical Weapons Exposure

    SBC: ZYMERON CORPORATION            Topic: CBD161003

    The skin is the first line of defense against chemical warfare agents including nerve agents and toxic industrial chemicals, providing a possible barrier or delay to systemic distribution. Some chemicals also can act directly on the skin including the vesicants sulfur mustard and lewisite. Early and rapid skin decontamination is extremely important following exposure to CWAs and TICs because it de ...

    SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government